Short-read Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Workflow, By Application, By End-Use, By Region, And Segment Forecasts, 2023 - 2030

Short-read Sequencing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Workflow, By Application, By End-Use, By Region, And Segment Forecasts, 2023 - 2030


Short-read Sequencing Market Growth & Trends


The global short-read sequencing market size is expected to reach USD 18.67 billion by 2030, expanding at 18.46% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising demand for personalized medicine and companion diagnostics is anticipated to drive the demand for short-read technologies. In addition, initiatives taken by key players to enhance their market presence are expected to boost revenue generation opportunities in the short-read sequencing industry. For instance, in January 2023, Illumina Inc. collaborated with Nashville Biosciences LLC and Amgen to conduct the whole-genome sequencing of around 35,000 DNA samples.

Other major players have also entered into partnerships and collaborations for the expansion of short-read technologies in the Asia Pacific. The region offers a large customer pool of patients suffering from chronic disorders that can be diagnosed easily using short-read methods. Major application areas of short-read methods include reproductive screening, oncology, noninvasive prenatal testing, infectious disease, and pharmacogenomics. Furthermore, a rise in the adoption of sequencing platforms for genomic research purposes is expected to have a positive impact on the overall market growth.For instance, in July 2022, IISc, Bengaluru launched a sequencing lab for virus genome sequence analysis studies. The lab also received funding from CryptoRelief to combat the COVID-19 pandemic.

Moreover, the COVID-19 pandemic resulted in increased exposure to the new strains of the SARS-CoV-2 virus which displayed a high level of contagiousness and resistance to drugs and treatments. Early detection of the virus variant lineage was essential to treat the viral infection and improve public health prospects. Although the market was negatively affected in 2020 due to the lockdowns, short-read genome analysis methods were in the growing demand for virus characterization and had a positive impact on the global short-read sequencing industry in 2021. In addition, the pandemic also led to increasing awareness about short-read techniques, which coupled with the development of cost-effective genome sequencing approaches is expected to boost revenue.

Short-read Sequencing Market Report Highlights

  • By product, the consumables segment dominated the market with a share of 62.65% in 2022. The high use of consumables such as micropipettes, assay kits, and others as well as repeat purchase of these products is driving the demand for short-read consumables
  • Sequencing accounted for the largest share of 56.64% in the workflow segment in 2022. The high penetration of the market participants in this step of the workflow adds to the robust revenues generated from the step
  • By application, the targeted sequencing & resequencing segment captured a majority share of 68.21% in 2022 due to its increasing applications in the research for the detection and treatment of cancer and other chronic diseases
  • The academic & research institutes segment accounted for the largest market share of 48.67% in 2022 due to the growing research infrastructure and a surge in the development of healthcare facilities which drive the segment to dominate the end-use segment
  • North America has established a strong regional position in the market with a 49.77% share in 2022. This is due to the increasing government funding leading to the increase in the research and development activities in this region
Please note The report will be delivered in 3-8 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Information Procurement
1.2. Information or Data Analysis
1.3. Market Scope & Segment Definition
1.4. Market Model
1.4.1. Market Study, By Company Market Share
1.4.2. Regional Analysis
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Segmentation and Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Trends and Outlook
3.4. Market Dynamics
3.4.1. Increasing adoption of Short-read sequencing due to its cost - effectiveness and short run times
3.4.2. Decreasing costs for genetic sequencing
3.4.3. Rise in the adoption of Short-read sequencing for personalized medicine and companion diagnostics
3.5. Market Restraint Analysis
3.5.1. Limitation of Short-read sequences to resolve complex genomic
3.5.2. Ethical and legal challenges associated with genomic sequencing
3.6. Penetration and Growth Prospect Mapping 2022
3.7. Business Environment Analysis
3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
3.7.2. Porter’s Five Forces Analysis
3.8. COVID - 19 Impact Analysis
Chapter 4. Product Business Analysis
4.1. Short-read sequencing market: Product Movement Analysis
4.2. Instruments
4.2.1. Instruments Market, 2018 - 2030 (USD Million)
4.3. Consumables
4.3.1. Consumables Market, 2018 - 2030 (USD Million)
4.4. Services
4.4.1. Services Market, 2018 - 2030 (USD Million)
Chapter 5. Workflow Business Analysis
5.1. Short-read sequencing market: Workflow Movement Analysis
5.2. Pre - Sequencing Market, 2018 - 2030 (USD Million)
5.3. Sequencing
5.3.1. Sequencing Market, 2018 - 2030 (USD Million)
5.4. Data Analysis
5.4.1. Data Analysis Market, 2018 - 2030 (USD Million)
Chapter 6. Application Business Analysis
6.1. Short-read sequencing market: Application Movement Analysis
6.2. Whole Genome Sequencing
6.2.1. Whole Genome Sequencing Market, 2018 - 2030 (USD Million)
6.3. Whole Exome Sequencing
6.3.1. Whole Exome Sequencing Market, 2018 - 2030 (USD Million)
6.4. Targeted Sequencing & Resequencing
6.4.1. Targeted Sequencing & Resequencing Market, 2018 - 2030 (USD Million)
6.4.2. DNA - based, Market, 2018 - 2030 (USD Million)
6.4.3. RNA - based, Market, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. End - Use Business Analysis
7.1. Short-read sequencing market: End - Use Movement Analysis
7.2. Academic & Research Institutes
7.2.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
7.3. Hospitals & Clinics
7.3.1. Hospitals & Clinics Market, 2018 - 2030 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
7.4.1. Pharmaceutical & Biotechnology Companies Market, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Short-read Sequencing Market Share By Region, 2022 & 2030
8.2. North America
8.2.1. SWOT Analysis
8.2.2. North America Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.2.3. U.S.
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. U.S. Short-read Sequencing Market, 2018 - 2030 (USD MILLION)
8.2.4. Canada
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Canada Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. SWOT Analysis
8.3.2. Europe Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.4. U.K.
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. U.K. Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.5. France
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. France Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.6. Italy
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Italy Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.7. Spain
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Spain Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.8. Denmark
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Denmark Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.9. Sweden
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Sweden Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.3.10. Norway
8.3.10.1. Key Country Dynamics
8.3.10.2. Competitive Scenario
8.3.10.3. Regulatory Framework
8.3.10.4. Norway Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. SWOT Analysis
8.4.2. Asia Pacific Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.4.3. Japan
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. Japan Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.4.4. China
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. China Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.4.5. India
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. India Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. South Korea Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.4.7. Australia
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Australia Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.4.8. Thailand
8.4.8.1. Key Country Dynamics
8.4.8.2. Competitive Scenario
8.4.8.3. Regulatory Framework
8.4.8.4. Thailand Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. SWOT Analysis
8.5.2. Latin America Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.5.3. Brazil
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Brazil Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.5.4. Mexico
8.5.4.1. Key Country Dynamics
8.5.4.2. Competitive Scenario
8.5.4.3. Regulatory Framework
8.5.4.4. Mexico Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.5.5. Argentina
8.5.5.1. Key Country Dynamics
8.5.5.2. Competitive Scenario
8.5.5.3. Regulatory Framework
8.5.5.4. Argentina Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. SWOT Analysis
8.6.2. MEA Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. South Africa Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.6.4. Saudi Arabia
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. Saudi Arabia Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.6.5. UAE
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. UAE Short-read Sequencing Market, 2018 - 2030 (USD Million)
8.6.6. Kuwait
8.6.6.1. Key Country Dynamics
8.6.6.2. Competitive Scenario
8.6.6.3. Regulatory Framework
8.6.6.4. Kuwait Short-read Sequencing Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Profiles/Listing
9.3.1. Illumina, Inc.
9.3.1.1. Overview
9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.1.3. Product Benchmarking
9.3.1.4. Strategic Initiatives
9.3.2. Thermo Fisher Scientific, Inc.
9.3.2.1. Overview
9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.2.3. Product Benchmarking
9.3.2.4. Strategic Initiatives
9.3.3. Pacific Biosciences of California, Inc.
9.3.3.1. Overview
9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.3.3. Product Benchmarking
9.3.3.4. Strategic Initiatives
9.3.4. BGI
9.3.4.1. Overview
9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.4.3. Product Benchmarking
9.3.4.4. Strategic Initiatives
9.3.5. QIAGEN
9.3.5.1. Overview
9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.5.3. Product Benchmarking
9.3.5.4. Strategic Initiatives
9.3.6. Agilent Technologies
9.3.6.1. Overview
9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.6.3. Product Benchmarking
9.3.6.4. Strategic Initiatives
9.3.7. PerkinElmer, Inc.
9.3.7.1. Overview
9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.7.3. Product Benchmarking
9.3.7.4. Strategic Initiatives
9.3.8. ProPhase Labs, Inc. (Nebula Genomics)
9.3.8.1. Overview
9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.8.3. Product Benchmarking
9.3.8.4. Strategic Initiatives
9.3.9. Psomagen
9.3.9.1. Overview
9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.9.3. Product Benchmarking
9.3.9.4. Strategic Initiatives
9.3.10. Azenta US, Inc. (GENEWIZ)
9.3.10.1. Overview
9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.3.10.3. Product Benchmarking
9.3.10.4. Strategic Initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings